Third Age Health Services (TAH) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
16 Jun, 2026Executive summary
Net Profit After Tax (NPAT) rose 115% year-over-year to $1,154k for the six months ended 30 September 2024, with underlying NPATA up 96% to $1,361k and 34% sequentially from 2H24.
Patient base expanded to 25,810, up 132% year-over-year, and the number of aged residential care facilities serviced increased to 87, a 23-facility increase over the prior comparable period.
Acquisition of Hub Aged Care in April 2024 contributed to growth, adding 13 facilities and 733 residents in the Lower North Island.
Community general practices showed significant operational improvement, though some underperformance remains.
Financial highlights
Revenue increased to $9,413k, up 28% year-over-year and 21% sequentially from 2H24.
EBITDA rose to $2,253k from $1,300k year-over-year.
Basic and diluted EPS doubled to 10.25 cents from 5.45 cents year-over-year.
Net cash from operating activities was $1,533k, up from $794k in the prior year.
Interim dividends declared for the first half totaled 6.83 cps, up 72% year-over-year.
Outlook and guidance
Management is cautiously optimistic that second-half performance will exceed the first half.
Capital allocation will continue to prioritize customer-focused investments, opportunistic debt repayment, and share buybacks.
Second quarter fully imputed dividend per share of 3.55 cents declared, totaling 6.83 cents for 1H25.
Latest events from Third Age Health Services
- NPATA up 36.3% YoY to $1,025k, driven by strong ARC revenue and margin expansion.TAH
Q1 2027 TU - Q3 FY26 revenue up 23.3% YoY, underlying NPATA up 22.1%, 4.00 cent dividend declared.TAH
Q3 2026 TU - Revenue up 17.9% YoY, underlying NPATA up 25.9%, and total FY26 dividends at 16.00 cents.TAH
H2 2026 - Statutory NPAT surged 236% to $1.38m on 35% revenue growth, with strong ARC expansion.TAH
H2 2024 - Underlying NPATA up 69% and revenue up 26%, with strong growth in ARC and General Practice.TAH
H2 2025 - NPAT up 32% and revenue up 13.2% year-over-year, driven by acquisitions and ARC expansion.TAH
H1 2026 - Strong profit growth and a new fixed dividend policy highlight robust Q1 FY26 performance.TAH
Q1 2026 TU - Revenue and profit surged in Q1 FY25, supported by acquisitions and patient growth.TAH
Q1 2025 TU - Q3 FY25 saw strong profit growth, margin expansion, higher dividends, and robust patient gains.TAH
Q3 2025 TU